AstraZeneca furthers ambition to redefine cancer care with first data from four major ...

AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...
The Malaysian Reserve

U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ ...

Updated indication allows the use of RINVOQ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom ...
The Malaysian Reserve

Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...